The role of hormonal therapy in the treatment of prostatic carcinoma.
Di Silverio
F
F
Dipartimento di Urologia U. Bracci, Cattedra di Urologia I, Università La Sapienza, Roma, Italy.
D'eramo
G
G
Caponera
M
M
Flammia
G P
GP
Izzi
R
R
Sciarra
A
A
Macrì
D
D
Buscarini
M
M
D000368:Aged; D000818:Animals; D002369:Castration; D003131:Combined Modality Therapy; D017373:Cyproterone Acetate / Q000627:therapeutic use; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use; D017273:Goserelin / Q000627:therapeutic use; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009857:Oncogenes; D011388:Prolactin / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*
D012739:Gonadal Steroid Hormones; D017273:Goserelin; D017373:Cyproterone Acetate; D011388:Prolactin; D013006:Growth Hormone